Absolute Investment Advisers LLC Cuts Position in abrdn Life Sciences Investors (NYSE:HQL)

Absolute Investment Advisers LLC decreased its holdings in shares of abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 51.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,378 shares of the company's stock after selling 207,148 shares during the quarter. Absolute Investment Advisers LLC owned about 0.67% of abrdn Life Sciences Investors worth $2,441,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Flagship Harbor Advisors LLC raised its holdings in abrdn Life Sciences Investors by 36.1% during the 1st quarter. Flagship Harbor Advisors LLC now owns 340,877 shares of the company's stock valued at $4,326,000 after acquiring an additional 90,436 shares during the period. LPL Financial LLC raised its holdings in abrdn Life Sciences Investors by 82.0% during the 4th quarter. LPL Financial LLC now owns 287,095 shares of the company's stock valued at $3,767,000 after acquiring an additional 129,313 shares during the period. Raymond James Financial Inc. bought a new position in shares of abrdn Life Sciences Investors in the fourth quarter worth $3,129,000. Allspring Global Investments Holdings LLC increased its holdings in shares of abrdn Life Sciences Investors by 16.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 193,484 shares of the company's stock worth $2,455,000 after purchasing an additional 27,433 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in shares of abrdn Life Sciences Investors by 7.5% in the fourth quarter. Ameriprise Financial Inc. now owns 153,396 shares of the company's stock worth $1,999,000 after purchasing an additional 10,742 shares during the period. Institutional investors own 32.21% of the company's stock.

Insider Buying and Selling at abrdn Life Sciences Investors

In other news, major shareholder Saba Capital Management, L.P. sold 30,156 shares of the company's stock in a transaction on Thursday, April 10th. The shares were sold at an average price of $11.14, for a total value of $335,937.84. Following the transaction, the insider owned 3,094,316 shares of the company's stock, valued at approximately $34,470,680.24. This represents a 0.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have sold a total of 92,544 shares of company stock valued at $1,087,994 over the last quarter. Corporate insiders own 10.06% of the company's stock.

abrdn Life Sciences Investors Trading Down 1.4%

Shares of abrdn Life Sciences Investors stock traded down $0.18 during trading on Monday, hitting $12.91. The stock had a trading volume of 87,094 shares, compared to its average volume of 107,438. abrdn Life Sciences Investors has a 12 month low of $10.55 and a 12 month high of $15.90. The business's 50-day moving average is $12.59 and its 200 day moving average is $12.93.

abrdn Life Sciences Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Thursday, May 22nd were issued a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 22nd. This represents a $1.72 annualized dividend and a dividend yield of 13.32%.

abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.